  | Absil, L., Rigaux, E., Tafforeau, L., Body, J.-J., Nonclercq, D., & Journe, F. (01 April 2021). Involvement of FXR in the OPG/RANKL pathway of breast and prostate cancer cells. Bone Reports, 14, 101036. doi:10.1016/j.bonr.2021.101036  Peer reviewed vérifié par ORBi |
 | Absil, L., Journe, F., Larsimont, D., Body, J.-J., Tafforeau, L., & Nonclercq, D. (10 July 2020). Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells. BMC Cancer, 20, 640. doi:10.1186/s12885-020-07106-7 Peer reviewed vérifié par ORBi |
Absil, L., Journe, F., & Nonclercq, D. (13 September 2018). Role of the farnesoid X receptor in the osteotropism of breast cancer cells [Paper presentation]. GIGA - cancer days 2018, Liège, Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (08 June 2018). The role of FXR in the osteomimetism in MCF-7 Breast Cancer Cells [Poster presentation]. Belgian Society for Cell and Development Biology, Liège, Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (27 March 2018). The role of FXR in the osteomimetism in MCF-7 Breast Cancer Cells [Poster presentation]. Mardi des Chercheurs (MdC2018), Valenciennes, France. |
Absil, L., Journe, F., & Nonclercq, D. (07 March 2018). Implication du FXR dans l'ostéomimétisme des cellules cancéreuses mammaires MCF-7 [Paper presentation]. Journée doctorale transfrontalière, Reims, France. |
Absil, L., Journe, F., & Nonclercq, D. (01 February 2018). The role of FXR in the osteomimetism in MCF-7 Breast Cancer Cells [Poster presentation]. télévie Cancer Seminar, Bruxelles (Erasme), Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (07 November 2017). Osteotropism induced by CDCA is interfered by lithocholic acid in breast cancer [Paper presentation]. European Gynecological Oncology Congress, Vienna, Austria. |
Absil, L., Journe, F., & Nonclercq, D. (18 May 2017). Osteotropism in MCF-7 Breast Cancer Cells [Poster presentation]. BIT's 10th Annual World Cancer Congress 2017, Barcelona, Spain. |
Absil, L., Journe, F., Saussez, S., & Nonclercq, D. (07 March 2017). Chenodeoxycholic acid (CDCA) promotes osteomimetism in MDA-MB-231 cells [Poster presentation]. Huitième édition montoise du MdC : le Mardi des Chercheurs 2017, UMons, Belgium. |
 | Valentini, X., Absil, L., laurent, G., Robbe, A., Laurent, S., Muller, R., Legrand, A., & Nonclercq, D. (30 January 2017). Toxicity of TiO2 nanoparticules on the NRK52E renal cell line. Molecular and Cellular Toxicology, 13, 419-431. doi:10.1007/s13273-017-0046-1 Peer reviewed |
Absil, L., Journe, F., Saussez, S., & Nonclercq, D. (08 December 2016). Bile acids promote osteomimetism in MDA-MB-231 cells [Poster presentation]. télévie's Researchers Seminar, UCL Bruxelles, Belgium. |
Valentini, X., Absil, L., laurent, G., Frau, A., Rugira Uwamahoro, P., & Nonclercq, D. (08 September 2016). Study of the oxidative stress caused by the exposure to TiO2 nanoparticles in vitro and in vivo [Poster presentation]. RBSM Golden Jubilee Meeting of the Royal Belgium Society for Microscopy, Bruxelles, Belgium. |
Absil, L., Journe, F., laurent, G., Larsimont, D., Saussez, S., Body, J.-J., & Nonclercq, D. (08 September 2016). Bile acids and estrogens promote the cell proliferation and osteomimetism in MCF-7 cells [Poster presentation]. RBSM Golden Jubilee Meeting of the Royal Belgium Society for Microscopy, Bruxelles, Belgium. |
Absil, L., Journe, F., laurent, G., Larsimont, D., Saussez, S., Body, J.-J., & Nonclercq, D. (01 July 2016). Farnesoid X receptor expression predicts bone metastases from breast cancer [Poster presentation]. Opening Symposium of the ULB- cancer research centre, Brussels, Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (27 May 2016). FXR is involved in the control of cell proliferation in breast cancer cells [Poster presentation]. Stem Cells as Disease Model and for Gene Therapy, Brussels, Belgium. |
Absil, L., Journe, F., & Nonclercq, D. (18 May 2016). Implication du FXR dans la prolifération cellulaire des cellules de carcinomes mammaires [Poster presentation]. Matinée des chercheurs, Valenciennes, Université de Valenciennes et du Hainaut Cambrésis, France. |
Absil, L., Journe, F., laurent, G., Frau, A., Ghanem, G., & Nonclercq, D. (30 January 2016). Phenotypic variations associated to V600EBRAF mutation among metastatic melanoma cell lines [Poster presentation]. BACR Annual Meeting, ULB Erasme, Belgium. |
Journe, F., Wiedig, M., Monrandini, R., El Hajj, P., Krayem, M., Sales, F., Theunis, A., Larsimont, D., Absil, L., Laurent, G., Gilot, D., Galibert, M.-D., Awada, A., & Ghanem, G. (08 March 2013). Tyrosine-related protein 1 (TYRP1) expression correlates with markers of both differentiation/pigmentation and proliferation in melanoma [Poster presentation]. Journée des doctorants, Bruxelles, Belgium. |